Context Therapeutics (CNTX) Change in Cash (2020 - 2026)

Context Therapeutics has disclosed Change in Cash across 7 years of filings, most recently posting -$11.5 million for Q1 2026.

• Change in Cash for Q1 2026 came in at -$11.5 million, down 125.83% year-over-year; the trailing twelve-month figure through Mar 2026 was -$34.8 million (down 143.93% YoY), and the FY2025 annual result was -$28.4 million, down 135.55% from the prior year.
• Change in Cash came in at -$11.5 million for Q1 2026 at Context Therapeutics, down from -$10.9 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $91.4 million in Q2 2024 to a low of -$16.7 million in Q3 2024.
• The 5-year median for Change in Cash is -$4.6 million (2023), against an average of $284882.9.
• Across the five-year window, Change in Cash tumbled 637.51% in 2022 and surged 2074.64% in 2024, its largest moves.
• Context Therapeutics' Change in Cash stood at -$3.9 million in 2022, then sank by 83.91% to -$7.2 million in 2023, then surged by 233.22% to $9.6 million in 2024, then sank by 213.65% to -$10.9 million in 2025, then slipped by 4.79% to -$11.5 million in 2026.
• The last three Change in Cash figures came in at -$11.5 million (Q1 2026), -$10.9 million (Q4 2025), and -$6.6 million (Q3 2025), per Business Quant data.